How to Help Your Patients Find Methotrexate in Stock: A Provider's Guide

With methotrexate injection still on the FDA shortage list in 2026, providers across rheumatology, oncology, and dermatology are fielding daily calls from patients who can't fill their prescriptions. Beyond clinical management, there is much a provider's office can do operationally to reduce the burden on patients and prevent dangerous treatment gaps.

Why Proactive Provider Support Matters

Most patients lack the information and connections needed to navigate a drug shortage effectively. They may not know to call hospital pharmacies, how to ask for compounded alternatives, or that their insurer may allow early refills during documented shortages. When providers and their staff proactively help, outcomes improve significantly.

Treatment interruptions for RA patients can cause disease flares that take months to bring back under control. For cancer patients, delays in methotrexate administration can compromise treatment efficacy. The stakes of inaction are high.

Step 1: Build a Pharmacy Resource List for Your Practice

Have your medical assistant or care coordinator maintain a running list of local pharmacies that have successfully filled methotrexate prescriptions for your patients in recent weeks. Update this list monthly. Key sources to include:

Hospital outpatient pharmacies affiliated with your system — these often have contracted supply of injectable methotrexate not available to retail chains

Local independent pharmacies — can sometimes source from different drug wholesalers than major chains

Specialty pharmacies that handle rheumatology or oncology medications

Infusion center pharmacies for patients who receive IV infusions

Step 2: Identify At-Risk Patients in Advance

Don't wait for patients to call in crisis. Use your EHR to identify patients currently prescribed injectable methotrexate with upcoming refill dates. Prioritize outreach for:

Patients on preservative-free methotrexate injection (highest risk — intrathecal use for cancer treatment)

Patients on high-dose IV protocols (cancer treatment)

Patients on subcutaneous MTX auto-injectors (RediTrex) who may not be able to transition to oral easily

Step 3: Prepare Clinical Contingency Plans in Advance

For RA and inflammatory arthritis patients, document in each chart in advance what the backup plan would be if methotrexate is unavailable. Options to pre-plan:

Switch injectable → oral methotrexate (note any prior GI intolerance in chart)

Leflunomide as alternative csDMARD (confirm no pregnancy plans, check baseline LFTs)

Prior authorization for a biologic if csDMARDs are likely to fail (initiate PA process early)

Step 4: Leverage Pharmacy Finder Tools for Your Patients

Services like medfinder for providers can be a practical addition to your shortage-management workflow. When a patient calls your office unable to fill their methotrexate, your staff can recommend medfinder to call pharmacies near the patient and identify available stock. This can resolve patient access issues within 24 hours and free up your staff's time.

Step 5: Communicate Clearly With Patients About the Shortage

Patients who understand the shortage are better able to take action and manage expectations. Recommended communication points:

Explain that the shortage is supply-chain-related — not a sign their medication was discontinued or that they need a different drug

Tell them to start looking 2–3 weeks before they run out, not when they're out

Assure them you have a clinical backup plan if they absolutely cannot find it

Document conversations in the chart in case insurance authorization is needed for alternatives

Important: Checking Your State's Early Refill Policies

Several states and some insurance plans allow early refills when a documented drug shortage exists. It's worth contacting the patient's pharmacy benefits manager (PBM) to request an override if the patient needs an early refill of their current supply while searching for a consistent pharmacy. This applies primarily to patients already stable on oral methotrexate.

For more on the clinical details of the methotrexate shortage and alternative management, see our clinical shortage guide for providers.